News & AnalysisBiomason nabs $65mBiomason, a North Carolina-based biotech startup, has raised $65 million in funding.ByIris Dorbian28 February 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs